Molbio Diagnostics acquires majority stake in Prognosys Medical Systems

Goa-based Molbio Diagnostics has acquired a 70 per cent stake in Bengaluru-based Prognosys Medical Systems, a manufacturer of the Prorad range of Digital X-Ray units and C-arms, the company said in a press statement on Monday.

The company said that the recent introduction of the unique Prorad Portable and Ultra-Portable digital x-ray units manufactured by Prognosys, can deliver high-quality chest images combined with Artificial Intelligence (AI) driven algorithms for automated interpreting and reporting at the point of care.

“The combination of Prorad and Truenat system offers a game-changing solution for screening and confirming large populations for highly contagious and devastating diseases such as TB, Covid and other chest anomalies,” Molbio said in the statement.

Speaking on the partnership, Sriram Natarajan, CEO, Founder, and Director, of Molbio Diagnostics, said “The majority acquisition of Prognosys Medical Systems Private Limited is yet another step in this direction and helps us expand our “Universal Access” portfolio. Such solutions are going to alter the way we identify and treat communicable and non-communicable diseases that are currently difficult to eradicate.”

Krishna Prasad, President, Prognosys said, “We are truly excited about this partnership with Molbio Diagnostics, a pioneer in the industry that develops pathbreaking technologies in molecular diagnostics and the IVD field. We are certain that with our combined capabilities to design and build world-class solutions in India, a true “Make in India” initiative, we will be able to significantly enhance the efforts of the government to eradicate deadly diseases like Tuberculosis.” BW Healthcareworld